Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel

Patents in South Korea and Israel cover integration of an external DNA sequence into the chromosome of eukaryotic cells

European Patent Office (EPO) to grant patent application

Merck wants to find out if and how one can increase curiosity

Merck develops alternative CRISPR genome editing method

Phil Baran about his research and what makes a good chemist

Grzybowski Scientific Inventions (GSI)’s Chematica can design chemically viable synthetic pathways for complex targets within seconds

85 % think that a curios person is more likely to bring an idea to life at work according to a study from Merck

Merck invests around € 30 million in Darmstadt, Germany

Stefan Oschmann appointed Executive Board Chairman and CEO of Merck KGaA